Patents Assigned to Ceva Santé Animale S.A.
  • Patent number: 12036275
    Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rIdeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: July 16, 2024
    Assignee: Ceva Santé Animale S.A.
    Inventors: Jana Seele, Christoph Baums, Peter Valentin-Weigand
  • Publication number: 20210015910
    Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rldeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
    Type: Application
    Filed: August 5, 2020
    Publication date: January 21, 2021
    Applicant: Ceva Santé Animale S.A.
    Inventors: Jana Seele, Christoph Baums, Peter Valentin-Weigand